Showing results (91-100 of 102) with videos related to
Sort By:
Pageof 11
Journal of Medicinal Chemistry|February 9, 2024
Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel WarheadN G R Dayan Elshan, Karen C Wolff, Laura Riva, et al.Nature Communications|June 4, 2021
Drug repurposing screens identify chemical entities for the development of COVID-19 interventionsMalina A Bakowski, Nathan Beutler, Karen C Wolff, et al.Journal of Medicinal Chemistry|June 8, 2011
Imidazolopiperazines: hit to lead optimization of new antimalarial agentsTao Wu, Advait Nagle, Kelli Kuhen, et al.Science Translational Medicine|December 6, 2013
Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosisSrinivasa P S Rao, Suresh B Lakshminarayana, Ravinder R Kondreddi, et al.Antimicrobial Agents and Chemotherapy|June 11, 2014
KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmissionKelli L Kuhen, Arnab K Chatterjee, Matthias Rottmann, et al.Nature|November 29, 2013
Targeting Plasmodium PI(4)K to eliminate malariaCase W McNamara, Marcus Cs Lee, Chek Shik Lim, et al.Nature|July 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13Inna V Krieger, Paridhi Sukheja, Baiyuan Yang, et al.Elife|September 30, 2025
A drug repurposing approach reveals targetable epigenetic pathways in <i>Plasmodium vivax</i> hypnozoitesSteven P Maher, Malina A Bakowski, Amélie Vantaux, et al.Nature|July 25, 2020
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposingLaura Riva, Shuofeng Yuan, Xin Yin, et al.Biorxiv : the Preprint Server for Biology|September 16, 2020
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19Britton Boras, Rhys M Jones, Brandon J Anson, et al.Pageof 11